Moleculin to Present at the 29th Annual Roth Capital Conference
HOUSTON, TX--(Marketwired - March 10, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are …